USPTO trademark

OMBAXVO

Awaiting publicationUSPTOWord markClass 5

"OMBAXVO" is a word mark owned by AstraZeneca Ireland Limited, filed at the USPTO on July 16, 2026. It is waiting to be published and covers class 5 (Pharmaceuticals).

View AstraZeneca Ireland Limited portfolioGet this data via the API
Official USPTO record
OMBAXVO trademark as filed
As filed with the USPTO
Status
Awaiting publication
Since October 21, 2026
Filed
July 16, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99944548
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns OMBAXVO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

AstraZeneca Ireland Limited

Dublin 15, Ireland

68 trademarks in the portfolioView company

Representative

Leonid Rakitin

AstraZeneca Pharmaceuticals LP

Goods and services

What the mark covers

The products and services OMBAXVO is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines; Antibodies for medical purposes

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Approved for pub - principal register
  2. Assigned to examiner
  3. Teas change of correspondence received
  4. Attorney/dom.rep.revoked and/or appointed
  5. Teas revoke/app/change addr of atty/dom rep received
  6. New application office supplied data entered
  7. Application filing receipt mailed
  8. New application entered
FAQ

About OMBAXVO

Who owns the trademark "OMBAXVO"?

The USPTO trademark "OMBAXVO" (application 99944548) is owned by AstraZeneca Ireland Limited.

What is the status of "OMBAXVO"?

Its status at the USPTO is: awaiting publication.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull OMBAXVO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019f7033-543e-74d1-b68a-6ceabe59b567
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019f7033-543e-74d1-b68a-6ceabe59b567",
  "object": "trademark",
  "mark_text": "OMBAXVO",
  "status": {
    "primary": "pending",
    "stage": "pending_publication"
  },
  "office_code": "US",
  "application_number": "99944548",
  "filing_date": "2026-07-16",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "AstraZeneca Ireland Limited",
      "entity_id": "ent_019eb7d2-439b-768c-9359-8ae13a3713f9"
    }
  ]
}